Theralase Technologies Inc. / Fundamentals
Income statement
- Net revenue
€652.47K - Cost of goods sold
€288.40K - Gross profit
€364.07K - SG&A expenses
€1.31M - R&D expenses
€1.69M - EBITDA
-€2.44M - D&A
€161.01K - EBIT
-€2.07M - Interest expenses
€12.73K - EBT
-€2.61M - Tax expenses
€0.00 - Net income
-€2.61M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€6.56K - Changes in working capital
€94.79K - Operating cash flow
-€1.95M - Capex
€55.80K - Other investing cash flow
€0.00 - Net investing cash flow
-€55.80K - Total cash dividends paid
€0.00 - Issuance of common stock
€1.86M - Debt repayment
-€79.44K - Other financing cash flow
-€1.22K - Net financing cash flow
€1.78M - Foreign exchange effects
€0.00 - Net change in cash
-€233.40K - Cash at end of period
€28.30K - Free cash flow
-€1.90M
Balance sheet
- Cash and cash equivalents
€28.30K - Cash and short-term investments
€28.30K - Total receivables
€489.20K - Inventory
€324.54K - Other current assets
€80.06K - Total current assets
€922.10K - Property, plant & equipment
€339.04K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€581.66K - Other non-current assets
-€1.83 - Total non-current assets
€920.70K - Total assets
€1.84M - Accounts payable
€651.90K - Short-term debt
€95.24K - Other current liabilities
€213.85K - Total current liabilities
€961.00K - Long-term debt
€101.98K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€101.98K - Total liabilities
€1.06M - Common stock
€30.36M - Retained earnings
-€42.72M - Other equity
€2.18M - Total equity
€779.81K - Total liabilities and shareholders' equity
€1.84M
Company information
- Market capitalization
€28.15M - Employees
14 - Enterprise Value
€46.42M
Company ratios
- Gross margin
-
55.8% Better than peer group: 42.7% - EBITDA margin
-
-374.0% Much better than peer group: -2,019.8% - EBIT margin
-
-317.3% Much better than peer group: -2,127.5% - EBT margin
-
-400.7% Much better than peer group: -2,036.7% - Net margin
-
-400.7% Much better than peer group: -2,068.3% - ROE
-
-335.2% Much worse than peer group: -78.8% - ROA
-
-141.9% Better than peer group: -151.1% - Asset turnover
-
35.4% Even with peer group: 34.1% - FCF margin
-
-308.1% Much better than peer group: -1,785.1% - FCF yield
-7.1% - Efficiency ratio
474.0% - Net sales per employee
-
€46.61K - Net income per employee
-
-€186.73K